Has traditional medicine had its day? The need to redefine academic medicine

Addressing Social Determinants of Mental Health in Pediatrics During the Coronavirus Disease 2019 Pandemic.

Global pandemic perspectives: public health, mental health, and lessons for the future

Why Adolescent Depression Is a Global Health Priority and What We Should Do About It

Quality of Life and Depression in CKD: Improving Hope and Health

Strategies to Improve Video Visit Use in Persons With Liver Disease

What Really Matters for Cancer Care – Health Systems Strengthening or Technological Innovation?

Familial hypercholesterolaemia (FH) is a dominant and highly penetrant monogenic disorder present from birth that markedly elevates plasma low-density lipoprotein (LDL)-cholesterol concentration and, if untreated, leads to premature atherosclerosis and coronary artery disease (CAD). There are approximately 100,000 people with FH in Australia. However, an overwhelming majority of those affected remain undetected and inadequately treated, consistent with FH being a leading challenge for public health genomics. To further address the unmet need, we provide an updated guidance, presented as a series of systematically collated recommendations, on the care of patients and families with FH. These recommendations have been informed by an exponential growth in published works and new evidence over the last 5 years and are compatible with a contemporary global call to action on FH. Recommendations are given on the detection, diagnosis, assessment and management of FH in adults and children. Recommendations are also made on genetic testing and risk notification of biological relatives who should undergo cascade testing for FH. Guidance on management is based on the concepts of risk re-stratification, adherence to heart healthy lifestyles, treatment of non-cholesterol risk factors, and safe and appropriate use of LDL-cholesterol lowering therapies, including statins, ezetimibe, proprotein convertase subtilisin/kexin type 9 inhibitors and lipoprotein apheresis. Broad recommendations are also provided for the organisation and development of health care services. Recommendations on best practice need to be underpinned by good clinical judgment and shared decision making with patients and families. Models of care for FH need to be adapted to local and regional health care needs and available resources. A comprehensive and realistic implementation strategy, informed by further research, including assessments of cost-benefit, will be required to ensure that this new guidance benefits all Australian families with or at risk of FH.

Redux: Do Little Bellyachers Grow up to Become Big Bellyachers?

The Future of Nursing 2020–2030: Charting a path to achieve health equity

Type 2 Diabetes in Aboriginal Peoples

Reconciling breast-feeding and early food introduction guidelines in the prevention and management of food allergy

Young Adults Are Worse Off Than Adolescents

SPN Position Statement: Transition of Pediatric Patients Into Adult Care

Putting public health back into the global cancer agenda

Cancer Risk Factors Among Adults with Serious Mental Illness